Andlauer Healthcare Group Inc.
AND.TO · TSX
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | CA$156,602 | CA$166,088 | CA$168,293 | CA$159,600 |
| % Growth | -5.7% | -1.3% | 5.4% | – |
| Cost of Goods Sold | CA$120,807 | CA$129,339 | CA$128,793 | CA$122,371 |
| Gross Profit | CA$35,795 | CA$36,749 | CA$39,500 | CA$37,229 |
| % Margin | 22.9% | 22.1% | 23.5% | 23.3% |
| R&D Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| G&A Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| SG&A Expenses | CA$16,918 | CA$15,183 | CA$12,761 | CA$13,423 |
| Sales & Mktg Exp. | CA$0 | CA$0 | CA$0 | CA$0 |
| Other Operating Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| Operating Expenses | CA$16,918 | CA$15,183 | CA$12,761 | CA$13,423 |
| Operating Income | CA$18,877 | CA$21,566 | CA$26,739 | CA$23,806 |
| % Margin | 12.1% | 13% | 15.9% | 14.9% |
| Other Income/Exp. Net | -CA$471 | CA$3,882 | -CA$2,639 | -CA$1,549 |
| Pre-Tax Income | CA$18,406 | CA$25,448 | CA$24,100 | CA$22,257 |
| Tax Expense | CA$4,956 | CA$5,223 | CA$6,572 | CA$5,971 |
| Net Income | CA$13,450 | CA$20,225 | CA$17,528 | CA$16,286 |
| % Margin | 8.6% | 12.2% | 10.4% | 10.2% |
| EPS | 0.34 | 0.5 | 0.45 | 0.41 |
| % Growth | -32% | 11.1% | 9.8% | – |
| EPS Diluted | 0.34 | 0.5 | 0.44 | 0.41 |
| Weighted Avg Shares Out | 39,152 | 40,278 | 39,251 | 39,390 |
| Weighted Avg Shares Out Dil | 39,813 | 40,885 | 39,836 | 39,955 |
| Supplemental Information | – | – | – | – |
| Interest Income | CA$305 | CA$323 | CA$260 | CA$494 |
| Interest Expense | CA$2,010 | CA$1,956 | CA$2,111 | CA$2,186 |
| Depreciation & Amortization | CA$17,994 | CA$17,937 | CA$17,621 | CA$17,371 |
| EBITDA | CA$38,410 | CA$45,341 | CA$43,832 | CA$41,814 |
| % Margin | 24.5% | 27.3% | 26% | 26.2% |